Food and Drug Administration

Oncologic Drugs Advisory Committee

December 18, 2002



The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

Casodex (bicalutamide) 15 mg, FDA Review, Dr. Dan Shames, MD and Dr. Scott Monroe, MD (HTM) (PPT)

Open Public Hearing

Comments (PDF)